Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(changed order) |
(layout) |
||
Line 39: | Line 39: | ||
|width=100px|{{#pwImage:Pathway:WP2001|250px||miR-targeted genes in adipocytes - TarBase}} | |width=100px|{{#pwImage:Pathway:WP2001|250px||miR-targeted genes in adipocytes - TarBase}} | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
- | |width=100px|{{# | + | |width=100px|{{#pwimage:Pathway:WP2910|250px||Mecp2 and Associated Rett Syndrome}} |
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP2029|250px||Cell Differentiation}} | |width=100px|{{#pwImage:Pathway:WP2029|250px||Cell Differentiation}} | ||
|width=100px|{{#pwImage:Pathway:WP2853|250px||Endoderm Differentiation}} | |width=100px|{{#pwImage:Pathway:WP2853|250px||Endoderm Differentiation}} | ||
|width=100px|{{#pwimage:Pathway:WP2858|250px||Ectoderm Differentiation}} | |width=100px|{{#pwimage:Pathway:WP2858|250px||Ectoderm Differentiation}} | ||
- | |width=100px|{{#pwimage:Pathway: | + | |width=100px|{{#pwimage:Pathway:WP2857|250px||Mesodermal Commitment Pathway}} |
|- | |- | ||
|width=100px|{{#pwimage:Pathway:WP673|250px||ErbB Signaling Pathway}} | |width=100px|{{#pwimage:Pathway:WP673|250px||ErbB Signaling Pathway}} | ||
- | |width=100px|{{#pwimage:Pathway: | + | |width=100px|{{#pwimage:Pathway:WP2904|250px||Mir302-367 Promoting Cardiomyocyte Proliferation}} |
- | + | ||
|width=100px|{{#pwimage:Pathway:WP2059|250px||Alzheimers Disease}} | |width=100px|{{#pwimage:Pathway:WP2059|250px||Alzheimers Disease}} | ||
|width=100px|{{#pwimage:Pathway:WP2371|250px||Parkinsons Disease}} | |width=100px|{{#pwimage:Pathway:WP2371|250px||Parkinsons Disease}} | ||
Line 58: | Line 57: | ||
|- | |- | ||
|width=100px|{{#pwimage:Pathway:WP1601|250px||Fluoropyrimidine Activity}} | |width=100px|{{#pwimage:Pathway:WP1601|250px||Fluoropyrimidine Activity}} | ||
- | |width=100px|{{#pwimage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP2249|250px||Metastatic Brain Tumor}} |
+ | |width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | ||
|} | |} |
Revision as of 06:10, 28 May 2015
Image does not exist |
Image does not exist |
Image does not exist Ozpolat, et al. Liposomal siRNA nanocarriers for cancer therapy Thomas, et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |